Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018

Similar documents
Harm Reduction in Nigeria

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

PROJECT BRIDGE: Differentiation of HIV Services for PWID in Harm Reduction Programs in Kazakhstan. Nabila El-Bassel, PhD Columbia University

Technical Guidance Note for Global Fund HIV Proposals

Targeted Outreach & Other Strategies for Increasing HCV Testing

Viral Hepatitis. WHO Regional Office for Europe July 2013

DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS

Hepatitis C Strategy. About us. What is hepatitis C?

Improving NSP and Harm Reduction Services. Jason Farrell, European HCV and Drug Use Initiative

Prevention Point Philadelphia

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

Guidelines For Services Providing Injecting Equipment

Primary Care Services for blood borne viral hepatitis prevention, treatment and care

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

WHO Strategy and Goals for Viral Hepatitis Elimination

World Health Organization. A Sustainable Health Sector

STRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS.

GLOBAL AIDS MONITORING REPORT

HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons

Becoming a harm reduction distribution agency in Toronto - information session

Available In person Courses

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

Direct Clinical Services

Opportunities For Hepatitis C Modalities in Substance Use Treatment Settings

As a result of this training, participants will be able to:

School Nursing and Health. Standard Precautions. (aka Universal Precautions)

QuADS Organisational Standards and Professional Competencies in needle exchange

As a result of this training, participants will be able to:

Arresting HIV in Malawi prisons

COUNTRY TABLE. MONTENEGRO.

PERFORMANCE AND IMAGE ENHANCING DRUGS

PH52. Audit tool for the implementation of. NICE public health guidance 52 Needle and syringe programmes

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

THE PORTUGUESE COMMUNITY SCREENING NETWORK

HIV and Hepatitis Prevention Programmes in Eastern Europe Case Example: Georgia

Building a New Approach to Health Care Services for Hard to Reach Clients

Local Legislative Approval and Program Certification

Saskatchewan HIV Strategy: Social Network Approach

HIV AND PEOPLE WHO INJECT DRUGS

Note: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.

IMPORTANCE OF PEER-BASED SERVICES & NEEDLE & SYRINGE PROGRAMS (NSP)

Hepatitis C in Massachusetts Epidemiology and Public Health Response

who use drugs in order to assist them in reducing harm while in the cycle of addiction

Getting to Zero in California: Integration of HIV Prevention and Surveillance

HIV Prevention, Care and Treatment Services in Prisons of North-Eastern States of India

HIV, drugs and the legal environment

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

Background: Kirketon Road Centre

Strategies to enhance HCV testing, linkage to care and treatment

Obstacles and Opportunities on Our Path Toward Eliminating Viral Hepatitis

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

KAZAKHSTAN. National Focal Point. Drug Abuse and Drug Dependence Treatment Situation. Territory : 2,717,300 km 2 Capital: Astana BASIC DATA

Low dead space. injecting equipment. from exchangesupplies.org

Meeting People Where they Are: Hepatitis C, Wound care and Syringe Access. Heather Lusk, MSW

ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin

PREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES

Models of good practice in drug treatment in Europe. Project group

Promoting hepatitis B vaccination

Treatment of Hepatitis C in People Who Inject Drugs (PWIDs) Andrew Seaman, MD OHA P&T Meeting January, 2017

Best Prac*ces Model for Harm Reduc*on in Bri*sh Columbia: Community Involvement

Infectious and Communicable Diseases Prevention and Control Program Annual Service Plan A. Community Need and Priorities We are situated rurally with

Hepatitis C Hepatitis C

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

Understanding Key Populations: Removing Legal Barriers to Prisons Health and Human Rights. Nthabiseng Mokoena

Government of Canada Federal AIDS Initiative Milestones

TB/HIV Care s Experience Setting up PrEP Sites and Engaging Potential Service Users. John Mutsambi and Peggy Modikoe TB/HIV Care

Groups of young people in Uganda that need to be targeted with HIV interventions

Modernization of North Carolina s HIV control measures

Version for the Silent Procedure 29 April Agenda item January Hepatitis

26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,

January Treatment Centre. December Drop-In Centre. November Regional Office

Greater Glasgow and Clyde. Blood Borne Viruses: Some important basic facts

Needle Exchange Programs

Civil Society Driven Response in Ukraine: A program making a difference and bringing results

HIV, HBV and HCV testing policy experiences and lessons learned.

TANZANIA NATIONAL STRATEGIC PLAN FOR CONTROL OF VIRAL HEPATITIS

Carol Strike, PhD & Tara Marie Watson, PhD and the Working Group on Best Practice for Harm Reduction Programs in Canada

Rolling up HCV treatment programs for PWIDs in Ukraine

Building Local Capacity for Treatment & Cure

Dr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia

High Impact Prevention for People Who Inject Drugs. June 30, 2015

Syringe Exchange An Intervention that Works to Control the Spread of Hepatitis C and HIV. Health Department

Understanding the Routine Contract Manager Report: Guidance for Funded Agencies

Toronto Declaration: Strategies to control and eliminate viral hepatitis globally. A call for coordinated action

SIXTY-SECOND WORLD HEALTH ASSEMBLY A62/22 Provisional agenda item April Viral hepatitis. Report by the Secretariat

Preventing Harm from Substance Use: Harm Reduction. July 6, Dr. Murray Fyfe Medical Health Officer Vancouver Island Health Authority

PREVENTION OF HCV IN PEOPLE WHO INJECT DRUGS

Syringe Exchange Programs December 2005

Quality improvement of the viral load programme in Mopani District, Limpopo Province

Hepatitis prevention in the context of HIV prevention point work in Latvia

ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES

Syringe Access & Disposal Services in SF

Hepatitis B and C Basics

SIXTY-SEVENTH WORLD HEALTH ASSEMBLY A67/13 Provisional agenda item March Hepatitis

Housing Ready vs. Housing First. Mission: 2/21/17

Essential minimum package ALHIV service provision: Community level

Utilizing CQI to Improve the Health of Supportive Housing Residents The North American Housing and HIV/AIDS Research Summit VII September 25-27, 2013

Transcription:

Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018

Overview Background to injecting drug use Overview of harm reduction Data on Hepatitis Summary of services provided by the Step Up Project Data from service delivery (January June 2018) Conclusions

Background The People Who Inject Drugs (PWID) projects aims to decrease and prevent the spread of HIV, TB and other bloodborne diseases by providing comprehensive harm reduction and HIV prevention programme to the PWID community. The use of contaminated injecting equipment has shown high risks of transmission of blood-borne diseases such as HIV and Hepatitis. Harm Reduction services started in March 2017 in Nelson Mandela Bay

What is Harm Reduction? A set of practical strategies and ideas aimed at reducing negative consequences associated with drug use. A philosophy promoting sensible, realistic solutions to problems related to drug use, utilising respectful and compassionate approaches. Services include safe spaces, commodities, health care, or education. Attempts to: 1. Prevent HIV and hepatitis C infections 2. Prevent overdose 3. Offer guidance and support for infections and co-morbidity 4. Prevent high-risk injecting and unsafe sex behaviours

Viral Hepatitis data Sep 2017 Mar 2018

Background Viral hepatitis is the inflammation of the liver due to viral infection. Hepatitis can be caused by heavy alcohol use, toxins, medication, supplements and certain medical conditions. The use of contaminated injecting equipment put PWID at risk of diseases such as Hepatitis which is a blood-borne disease. There is a vaccination available for HBV but no treatment and there is no vaccination for HCV but direct treatment is available. A study done by TB HIV Care in Cape Town, Pretoria and Durban with PWID has shown a high prevalence of HCV in PWID with 29% in Durban and 73% in Pretoria. The need of harm reductions services to PWID community is essential in order to prevent the spread and transmission of HCV and HIV.

Methods Outreach team educated service users of viral hepatitis B & C. Services users were then recruited for viral hepatitis B & C testing. Bloods were taken. Follow up appointments were arranged for clients who were tested Hep C positive with a Hepatologist. Confirmatory tests (HCV VL) were done.

No. of clients tested for hep C Viral Hepatitis C data among People Who Inject Drugs NMB Sep 2017 March 2018 30 22 73% 12 55% 1 33% HCV screening test HCV Pos Referred HCV Pos Confirmatory

No. of clients tested for Hep B Viral Hepatitis B among People Who Inject Drugs in NMB Sep 2017 Mar 2018 31 8 26% HBV Screening test HBV Pos

Conclusion and Recommendation Conclusion There is a high prevalence of HCV among PWID in NMB. Health education is provided to the service users on Hepatitis B & C so as to prevent transmission. Follow up appointments are arrange for service users that have tested positive for Hep C but due to the fact that there is no treatment available/accessible services users feel discourage to attend appointments. Due to having no treatment accessible/available services users feel discourage to test. Recommendations Advocacy for Hepatitis C treatment is essential.

Data People Who Inject Drugs Nelson Mandela Bay Jan Jun 2018

The Step Up project provides*: Needle and syringe services HIV testing and counseling & referrals, including ART Prevention of sexually transmitted infections Condom distribution Information, education and communication (IEC) material Prevention of tuberculosis (TB) Peer Educators deliver services to PWID twice weekly Prevention and education Wound care Advocacy and Human Rights Sensitivity training (clinics, police, community groups, etc.) *As recommended by the WHO

No. of unique clients Total number of unique clients reached by gender and race NMB Jan June 2018 n=361 Gender and Age 283 284 76 1 1 30 5 42 0 Males Females Transmale Transfemale Blacks Indians Coloureds Whites Other

No. reached Total Unique PWIDs reached by age NMB Jan June 2018 n=361 93 71 51 55 36 13 23 12 4 3 0 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65+ Age

No. of needles/syringe 12950 7434 8918 10304 70% 7165 9730 80% 7754 76% 9847 11298 7244 64% 58% 4304 62% 5502 Jan Feb Mar Apr May Jun Needles/Syringe Distibuted Needles/Syringe Returned

No. HIV positive clients 200 180 160 177 HIV Cascade NMB Jan Jun 2018 140 120 100 80 60 40 20 0 26 17 17 0 HIV Tested HIV Positive HIV linked to care HIV on ART Viral Suppression

No. of TB Screens TB Screens NMB Jan Jun 2018 177 5 4 4 4 SCREENED FOR TB FOUND TO BE SYMPTOMATIC TB DIAGNOSIS CONFIRMED TB TREATMENT STARTED TB TREATMENT COMPLETED TB Screens

No. of Human Rights violations Human Rights Violations NMB Jan June 2018 7 7 Total number of human violations reported Confiscation / destruction of injecting equipment 0 0 0 Assault Falsely arrested Other

Conclusions Successful linkage has improved from 60% - 65% due to the role of linkage officer, even so this needs to improve to meet the 90/90/90 goal. Good TB treatment outcome. Engagement with the law enforcement has seen a decrease in the human rights violations. Constant education on returning used needles with the service users has shown an increase in needles returned from 56% - 69%. Recommendations Engagement with department of health needs to be strengthened to receive clients viral load details.

Thank you! Siyasanga Ngcebetsha Siyasanga@tbhivcare.org Zoliswa Siguca zoliswas@tbhivcare.org Supported by: Funder logo here (if permission from funder has been granted) Funder logo here (if permission from funder has been granted)